Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy

BACKGROUND: Despite the advent of checkpoint inhibitors (CPIs) for advanced genitourinary (GU) cancers, existing studies suggest that durable complete responses are observed in fewer than 10% of patients. This study sought to evaluate the association between expectations of cure reported by patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergerot, Cristiane Decat, Bergerot, Paulo Gustavo, Philip, Errol J., Hsu, Jo Ann, Dizman, Nazli, Vaishampayan, Ulka, Dorff, Tanya, Pal, Sumanta Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416952/
https://www.ncbi.nlm.nih.gov/pubmed/30867071
http://dx.doi.org/10.1186/s40425-019-0557-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416952/
https://www.ncbi.nlm.nih.gov/pubmed/30867071
http://dx.doi.org/10.1186/s40425-019-0557-5

Ejemplares similares